Physician profile
Paul C Madlock
NPI 1558491514
$7,722.78
in general payments reported to CMS, 2019-2025
11 companies · $14.61 in 2025
The $14.61 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,883 · 2020: $780 · 2021: $227 · 2022: $363 · 2023: $217 · 2024: $237 · 2025: $14.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $5,558.45 | 2019-2023 | |
| Nobel Biocare USA | $796.21 | 2019-2022 | |
| Zyla Life Sciences, INC. | $390.55 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $303.49 | 2019-2020 | |
| Dentsply Sirona INC | $299.21 | 2019-2023 | Astra Tech Implant System, Atlantis |
| Straumann USA LLC | $168.67 | 2019-2024 | |
| Align Technology, INC. | $148.80 | 2024 | Invisalign |
| Pacira Pharmaceuticals Incorporated | $16.50 | 2023 | Exparel |
| Philips North America LLC | $14.61 | 2025 | Oral Health Care Undivided |
| Keystone Dental INC. | $13.36 | 2019 | |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $12.93 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Madlock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.